TrialDigestive diseases and sciences2018

Retreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir + Ribavirin for Hepatitis C Virus Genotype 4 Patients.

Adel Abdel-Moneim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.